Current state and upcoming opportunities for immunoPET biomarkers in lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current state and upcoming opportunities for immunoPET biomarkers in lung cancer

Published:2022-07 Issue: Volume:169 Page:84-93
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Slebe Maarten,Pouw Johanna E.E.,Hashemi Sayed M.S.,Menke-van der Houven van Oordt C. Willemien,Yaqub Maqsood M.,Bahce Idris

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference77 articles.

1. Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non–small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater;Reck;J. Clin. Oncol.,2019

2. R. Mestel, Cancer: Imaging with antibodies, Nature 2017 543:7647. 543 (2017) 743–746. 10.1038/543743a.

3. Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET;Bahce;Lung Cancer.,2017

4. The implementation of PET in non-small-cell lung cancer in the netherlands;van Tinteren;Clin. Oncol.,2006

5. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial;van Tinteren;Lancet,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioinformatics Study on Renin Angiotensin in Lung, and Liver Cancer Using Plant-Based Extracts;The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases;2023

2. Imaging Techniques in Pharmacological Precision Medicine;Precision Medicine;2023

3. Potential of Theranostics in Visualisation of the Tumour Microenvironment and Elimination of Its Immunosuppressive Components;The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation;2022-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3